Developed by Glaukos, the iDose TR (travoprost intraocular implant) 75 mcg is a new, FDA-approved treatment that is designed ...
Researchers identified two specific problems that led to vision loss among these patients. One group’s papilledema led to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback